Equities

Shield Therapeutics PLC

STX:LSE

Shield Therapeutics PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)9.60
  • Today's Change-0.40 / -4.00%
  • Shares traded1.94m
  • 1 Year change209.68%
  • Beta2.7036
Data delayed at least 20 minutes, as of Feb 06 2026 16:01 GMT.
More ▼

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2024202420232022
ASSETS
Cash And Short Term Investments6.52143.40
Total Receivables, Net23114.52
Total Inventory5.663.201.76
Prepaid expenses2.442.902.50
Other current assets, total0.50----
Total current assets383112
Property, plant & equipment, net0.370.670.24
Goodwill, net------
Intangibles, net181714
Long term investments------
Note receivable - long term------
Other long term assets------
Total assets574927
LIABILITIES
Accounts payable6.524.051.74
Accrued expenses178.779.98
Notes payable/short-term debt000
Current portion long-term debt/capital leases0.200.210.11
Other current liabilities, total9.190.701.01
Total current liabilities331413
Total long term debt26207.25
Total debt26207.35
Deferred income tax------
Minority interest------
Other liabilities, total------
Total liabilities593420
SHAREHOLDERS EQUITY
Common stock20155.37
Additional paid-in capital203199169
Retained earnings (accumulated deficit)(217)(190)(158)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(7.81)(8.45)(10)
Total equity(1.32)156.54
Total liabilities & shareholders' equity574927
Total common shares outstanding1,042782267
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.